Small-Cap Stock Watch: Key Catalysts This Week (March 23–27)

From corporate updates to investor events, we’ve tracked the full scope of small-cap catalysts slated for the week ahead.

--

Companies Attending the 38th Annual Roth Conference

The 38th Annual Roth Conference will be held from March 22–24, 2026, at The Ritz-Carlton Laguna Niguel in Dana Point, California. This invite-only event will feature company presentations, Q&A sessions, management one-on-one meetings, and industry panels, along with networking, entertainment, and athletic charity events. The conference highlights investment opportunities across a broad range of sectors, including technology and media, digital assets, sustainability, consumer, energy, healthcare, metals and mining, and engineering services.

Participating companies include: ● FFAI • GANX • XHLD • RSSS • REVB • STEX • PROP ● APVO • AIOT • BGIN • INV • ZEO • NAGE • EQ ● ANGX • RMNI • PSQH • HFFG • MBRX • ROLR • SKYX ● MBOT • FUSE • SRFM • ACON • ASPN • BRLT • PEW ● PPSI • CURI • OTH • KOPN • IPST • ATLN • MNOV ● CRON • LOOP • IPM • ARAI • FTCI • POWW • BRFH ● KBSX • ATCH • FLNT • GAIA • GRWG • DDC • ADGM ● ISPR • GTBP • XAIR • OMSE • GWH • AGIG • MSAI ● BEAT • FATN • FUFU • CRVO • CTW • XGN • BHST ● UPXI • MDCX • DFNS • NWTG • TKNO • SPWR • STKE

Other Companies with Material Events This Week

● RZLV — Will showcase its agentic commerce platform at Shoptalk 2026 from March 23–26, 2026, in Las Vegas, including live demonstrations and in-booth sessions focused on conversational commerce.

● SCNI — Will participate in BIO-Europe Spring 2026 from March 23–25, 2026, in Lisbon, marking its first major international conference following its Recipharm Israel acquisition, with meetings focused on its R&D pipeline and CDMO capabilities.

● TLPH — Will host a virtual investor and analyst event on March 23, 2026, at 11:00 a.m. ET, featuring investigators from the NEPHRO CRRT study evaluating Niyad.

● GNPX — Executive leadership will attend BIO-Europe Spring from March 23–25, 2026, in Lisbon, with one-on-one meetings to discuss its gene therapy programs for cancer and diabetes.

● SES — Will participate in the International Battery Seminar (March 23–24, 2026, Orlando) and the Energy Storage Summit USA (March 24–25, 2026, Dallas), including a panel on AI in battery discovery.

● EVGN — Will present at BIO-Europe Spring 2026 from March 23–25, 2026, in Lisbon, with leadership attending to engage with partners and investors.

● INVZ — CEO Omer Keilaf will host a public webinar on March 23, 2026, at 10:00 a.m. ET to discuss the company’s physical AI white paper and strategy.

● ENSC — Will participate in the U.S. Association for the Study of Pain Annual Scientific Meeting from March 23–26, 2026, in Philadelphia, including a presentation on next-generation pain therapeutics.

● TELO — Will participate in the 16th World Congress on Breast Cancer Research & Therapies from March 23–24, 2026, in Paris.

● GRCE — Will participate in the Society of Critical Care Medicine Congress from March 22–24, 2026, in Chicago, presenting data from its Phase 3 STRIVE-ON trial.

● AMZE — Will exhibit at Shoptalk Spring 2026 from March 24–26, 2026, in Las Vegas, showcasing its creator-driven commerce platform.

● AMBR — Will host a digital asset strategy webinar on March 24, 2026, from 3:00–4:00 PM (UTC+8), focusing on macro trends and institutional adoption.

● BMEA — Will participate in the BMO Metabolic Health Summit on March 24, 2026, including a panel discussion and investor meetings.

● XRTX — Entered an amendment extending the deadline to complete its acquisition of Vectus’ renal anti-fibrotic program to March 31, 2026.

● PMI — Will present new preclinical data on its Emperor Total Artificial Heart at ACC.26 from March 28–30, 2026, in New Orleans.

● IRD — Will present at the RBC Capital Markets Global Ophthalmology Conference on March 25, 2026, at 11:45 a.m. ET.

● SATL — Will participate in the Craig Hallum 2nd Annual NewSpace Conference on March 25, 2026, in a virtual format.

● IINN — Will showcase its FDA-cleared INSPIRA™ ART100 system at the AmSECT 64th International Conference from March 25–29, 2026, in Austin, Texas.

● VEEE — Will host an invitation-only Media Day on March 26, 2026, during the Palm Beach Boat Show to unveil the relaunch of Bahama Boat Works.

● MIST — Will present clinical data at ACC.26 from March 28–30, 2026, in New Orleans, including poster and expert theater sessions on March 29–30.

● BFRG — Will host an AI-focused webinar on March 27, 2026, at 11:00 a.m. ET discussing decision-making applications.

● LAES — Will participate in the Wi-SUN Open House in Tokyo on March 27, 2026, highlighting secure IoT and post-quantum solutions.

● RCKT — Has a PDUFA target action date for KRESLADI™ set for March 28, 2026.

● BRTX — Will release new data related to chronic lumbar disc disease on March 28, 2026, via a pre-market press release.

● IFRX — Will present Phase 3 vilobelimab data in a late-breaking oral session at the AAD Annual Meeting from March 27–31, 2026, in Denver.

● CNTB — Will present Phase 3 atopic dermatitis data at AAD 2026 on March 28, 2026, in a late-breaking oral session.

● ESPR — Will present two abstracts at ACC.26 from March 28–30, 2026, in New Orleans, with sessions on March 28 and March 29.

● BEAT — Will demonstrate its 12-lead ECG extended wear patch at ACC.26 from March 28–30, 2026, highlighting its potential as a best-in-class cardiac monitoring solution.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.